We from TCS are leveraging our human immune system models and knowledge to assist our customer in the fight against SARS-Cov2

Find out the details on how TransCure bioServices will improve human liver diseases research and development with its novel and innovative human hepatocytes (hu-liver) mouse models.

We have remodeled, expended, and totally refurbished our current animal facility to a state-of-the-art mouse facility of 500 m2 (5’300 ft2)

Our team, will be in Turin during the EACR, June 17th to 20th.